11 Jan 2023
SAHPRA registers new long-acting HIV pre-exposure prophylaxis
By Staff Writer
Cabotegravir (Apretude 600mg/3ml injection), a long-acting HIV pre-exposure prophylactic, was registered by the South African Health Products Regulatory Authority (SAHPRA) in December. Cabotegravir is an antiretroviral drug (ARV), which people living with HIV may use, together with other ARVs, to keep the virus in their bodies from making copies of itself. When such medicine is...
